The healthcare sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, hospitals, and health insurers. AI analysis examines pipeline progress, FDA approvals, revenue diversification, and profitability metrics from quarterly SEC filings.
Top Healthcare Stocks in 2026
Top-rated healthcare stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: June 2026
LLY
Confidence
86%
DXCM
Confidence
86%
ELTP
Confidence
84%
CRMD
Confidence
82%
IDXX
Confidence
82%
KRYS
Confidence
82%
ADUS
Confidence
82%
UTHR
Confidence
82%
RSMDF
Confidence
82%
NBIX
Confidence
81%
VRTX
Confidence
81%
ELMD
Confidence
80%
All Healthcare Stocks (897)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| ADTX | Aditxt, Inc. | D | 98% | View Analysis → |
| WLSS | Welsis Corp. | D | 98% | View Analysis → |
| SKVI | SKINVISIBLE, INC. | D | 98% | View Analysis → |
| SIGY | Sigyn Therapeutics, Inc. | D | 98% | View Analysis → |
| PIIIW | P3 Health Partners Inc. | D | 98% | View Analysis → |
| FCHS | First Choice Healthcare Solutions, Inc. | D | 98% | View Analysis → |
| PRPH | ProPhase Labs, Inc. | D | 97% | View Analysis → |
| SINT | Sintx Technologies, Inc. | D | 96% | View Analysis → |
| AIM | AIM ImmunoTech Inc. | D | 96% | View Analysis → |
| BRTX | BioRestorative Therapies, Inc. | D | 96% | View Analysis → |
| ARMP | Armata Pharmaceuticals, Inc. | D | 96% | View Analysis → |
| PCSC | Perceptive Capital Solutions Corp | D | 96% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | D | 96% | View Analysis → |
| KAYS | Kaya Holdings, Inc. | D | 96% | View Analysis → |
| RGPX | REGENEREX PHARMA, INC. | D | 96% | View Analysis → |
| LUDG | LUDWIG ENTERPRISES, INC. | D | 96% | View Analysis → |
| IRME | IR-Med, Inc. | D | 96% | View Analysis → |
| GCAN | Greater Cannabis Company, Inc. | D | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | D | 96% | View Analysis → |
| EMMA | Emmaus Life Sciences, Inc. | D | 96% | View Analysis → |
| EDGM | Edgemode, Inc. | D | 96% | View Analysis → |
| TRAW | Traws Pharma, Inc. | D | 95% | View Analysis → |
| TCRT | Alaunos Therapeutics, Inc. | D | 95% | View Analysis → |
| RVP | RETRACTABLE TECHNOLOGIES INC | D | 95% | View Analysis → |
| ISPC | iSpecimen Inc. | D | 95% | View Analysis → |
| VNRX | VOLITIONRX LTD | D | 95% | View Analysis → |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | D | 95% | View Analysis → |
| PCSA | Processa Pharmaceuticals, Inc. | D | 95% | View Analysis → |
| PAVM | PAVmed Inc. | D | 95% | View Analysis → |
| PTN | PALATIN TECHNOLOGIES INC | D | 95% | View Analysis → |
| TPST | Tempest Therapeutics, Inc. | D | 95% | View Analysis → |
| ACH | ACCENDRA HEALTH INC/VA/ | D | 95% | View Analysis → |
| SERA | SERA PROGNOSTICS, INC. | D | 95% | View Analysis → |
| ZVSA | ZyVersa Therapeutics, Inc. | D | 95% | View Analysis → |
| ZIVOW | Zivo Bioscience, Inc. | D | 95% | View Analysis → |
| YBGJ | Yubo International Biotech Ltd | D | 95% | View Analysis → |
| XAIR | Beyond Air, Inc. | D | 95% | View Analysis → |
| VICP | Vicapsys Life Sciences, Inc. | D | 95% | View Analysis → |
| VERO | Venus Concept Inc. | D | 95% | View Analysis → |
| VCNX | VACCINEX, INC. | D | 95% | View Analysis → |
| TVGNW | Tevogen Bio Holdings Inc. | D | 95% | View Analysis → |
| STSSW | Sharps Technology Inc. | D | 95% | View Analysis → |
| STME | Stimcell Energetics Inc. | D | 95% | View Analysis → |
| SNOA | Sonoma Pharmaceuticals, Inc. | D | 95% | View Analysis → |
| SMNRW | Semnur Pharmaceuticals, Inc. | D | 95% | View Analysis → |
| SLNCF | Silence Therapeutics plc | D | 95% | View Analysis → |
| SGP | SpyGlass Pharma, Inc. | D | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | D | 95% | View Analysis → |
| RTGN | RetinalGenix Technologies Inc. | D | 95% | View Analysis → |
| RTEZ | REST EZ Inc. | D | 95% | View Analysis → |
| OTLC | Oncotelic Therapeutics, Inc. | D | 95% | View Analysis → |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | D | 95% | View Analysis → |
| PREM | Premier Air Charter Holdings Inc. | D | 95% | View Analysis → |
| POSC | POSITRON CORP | D | 95% | View Analysis → |
| PMI | Picard Medical, Inc. | D | 95% | View Analysis → |
| PKTX | ProtoKinetix, Inc. | D | 95% | View Analysis → |
| NIKA | NIKA PHARMACEUTICALS, INC | D | 95% | View Analysis → |
| MDCXW | Medicus Pharma Ltd. | D | 95% | View Analysis → |
| MCUJF | MEDICURE INC | D | 95% | View Analysis → |
| MCLE | Medicale Corp. | D | 95% | View Analysis → |
| MGRX | MANGOCEUTICALS, INC. | D | 94% | View Analysis → |
| GALT | GALECTIN THERAPEUTICS INC | D | 94% | View Analysis → |
| ADGM | Adagio Medical Holdings, Inc. | D | 94% | View Analysis → |
| ABVC | ABVC BIOPHARMA, INC. | D | 94% | View Analysis → |
| CODX | Co-Diagnostics, Inc. | D | 94% | View Analysis → |
| BTAI | BioXcel Therapeutics, Inc. | D | 94% | View Analysis → |
| GCTK | Glucotrack, Inc. | D | 94% | View Analysis → |
| CLNN | Clene Inc. | D | 94% | View Analysis → |
| INO | INOVIO PHARMACEUTICALS, INC. | D | 94% | View Analysis → |
| BYSI | BeyondSpring Inc. | D | 94% | View Analysis → |
| MRAI | Marpai, Inc. | D | 94% | View Analysis → |
| MCAGU | Mountain Crest Acquisition Corp. V | D | 94% | View Analysis → |
| LYRA | Lyra Therapeutics, Inc. | D | 94% | View Analysis → |
| ITRM | Iterum Therapeutics plc | D | 94% | View Analysis → |
| GELS | Gelteq Ltd | C | 94% | View Analysis → |
| ERNAW | Ernexa Therapeutics Inc. | D | 94% | View Analysis → |
| ENSCW | Ensysce Biosciences, Inc. | D | 94% | View Analysis → |
| EMED | Electromedical Technologies, Inc | D | 94% | View Analysis → |
| EBRCZ | EBR Systems, Inc. | D | 94% | View Analysis → |
| BCDA | BioCardia, Inc. | D | 93% | View Analysis → |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 93% | View Analysis → |
| BCAB | BioAtla, Inc. | D | 93% | View Analysis → |
| ELTX | Elicio Therapeutics, Inc. | D | 93% | View Analysis → |
| IMTH | AnTix Holdings, Inc. | D | 93% | View Analysis → |
| IOBT | IO Biotech, Inc. | D | 93% | View Analysis → |
| INTI | Inhibitor Therapeutics, Inc. | D | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | D | 93% | View Analysis → |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | D | 93% | View Analysis → |
| EVFM | Evofem Biosciences, Inc. | D | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | D | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | D | 93% | View Analysis → |
| IVF | INVO Fertility, Inc. | D | 92% | View Analysis → |
| PSTV | PLUS THERAPEUTICS, INC. | D | 92% | View Analysis → |
| VVOS | Vivos Therapeutics, Inc. | D | 92% | View Analysis → |
| PPCB | Propanc Biopharma, Inc. | D | 92% | View Analysis → |
| JAGX | Jaguar Health, Inc. | D | 92% | View Analysis → |
| CNSP | CNS Pharmaceuticals, Inc. | D | 92% | View Analysis → |
| ATRA | Atara Biotherapeutics, Inc. | D | 92% | View Analysis → |
| STEX | Streamex Corp. | D | 92% | View Analysis → |
| TARA | Protara Therapeutics, Inc. | D | 92% | View Analysis → |
| SKYE | Skye Bioscience, Inc. | D | 92% | View Analysis → |
| SPRY | ARS Pharmaceuticals, Inc. | D | 92% | View Analysis → |
| CVM | CEL SCI CORP | D | 92% | View Analysis → |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D | 92% | View Analysis → |
| CRVO | CervoMed Inc. | D | 92% | View Analysis → |
| IBO | IMPACT BIOMEDICAL INC. | D | 92% | View Analysis → |
| PLUR | Pluri Inc. | D | 92% | View Analysis → |
| ARTL | ARTELO BIOSCIENCES, INC. | C | 92% | View Analysis → |
| SILO | Silo Pharma, Inc. | D | 92% | View Analysis → |
| VANI | Vivani Medical, Inc. | D | 92% | View Analysis → |
| SVRA | Savara Inc | D | 92% | View Analysis → |
| MAIA | MAIA Biotechnology, Inc. | D | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D | 92% | View Analysis → |
| GH | Guardant Health, Inc. | D | 92% | View Analysis → |
| ZEOX | Zeo ScientifiX, Inc. | D | 92% | View Analysis → |
| XCUR | EXICURE, INC. | D | 92% | View Analysis → |
| VACHW | Voyager Acquisition Corp./Cayman Islands | D | 92% | View Analysis → |
| PMHS | Polomar Health Services, Inc. | D | 92% | View Analysis → |
| ORGS | Orgenesis Inc. | D | 92% | View Analysis → |
| ONMDW | OneMedNet Corp | D | 92% | View Analysis → |
| ODYY | Odyssey Health, Inc. | D | 92% | View Analysis → |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | D | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | D | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | D | 92% | View Analysis → |
| RENXF | Renalytix plc | D | 92% | View Analysis → |
| NVACW | Profusa, Inc. | D | 92% | View Analysis → |
| NUMD | Nu-Med Plus, Inc. | D | 92% | View Analysis → |
| MDAIW | Spectral AI, Inc. | D | 92% | View Analysis → |
| MANE | Veradermics, Inc | D | 92% | View Analysis → |
| INDP | Indaptus Therapeutics, Inc. | D | 91% | View Analysis → |
| MBRX | Moleculin Biotech, Inc. | D | 91% | View Analysis → |
| NBY | NovaBay Pharmaceuticals, Inc. | D | 91% | View Analysis → |
| EVMN | Evommune, Inc. | D | 91% | View Analysis → |
| AMIX | Autonomix Medical, Inc. | D | 90% | View Analysis → |
| APUS | Apimeds Pharmaceuticals US, Inc. | C | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | D | 90% | View Analysis → |
| JUNS | JUPITER NEUROSCIENCES, INC. | D | 90% | View Analysis → |
| CNTB | Connect Biopharma Holdings Ltd | C | 90% | View Analysis → |
| APVO | Aptevo Therapeutics Inc. | D | 90% | View Analysis → |
| AKTX | Akari Therapeutics Plc | D | 90% | View Analysis → |
| ELAB | PMGC Holdings Inc. | D | 90% | View Analysis → |
| GOVX | GeoVax Labs, Inc. | D | 90% | View Analysis → |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | C | 90% | View Analysis → |
| CRIS | CURIS INC | C | 90% | View Analysis → |
| NOTV | Inotiv, Inc. | D | 90% | View Analysis → |
| XFOR | X4 Pharmaceuticals, Inc | D | 90% | View Analysis → |
| PCVX | Vaxcyte, Inc. | D | 90% | View Analysis → |
| QURE | uniQure N.V. | D | 90% | View Analysis → |
| VSEEW | VSEE HEALTH, INC. | D | 90% | View Analysis → |
| VGLS | VG Life Sciences Inc. | D | 90% | View Analysis → |
| TIVC | Tivic Health Systems, Inc. | D | 90% | View Analysis → |
| SSKN | STRATA Skin Sciences, Inc. | D | 90% | View Analysis → |
| ONCO | Onconetix, Inc. | D | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | D | 90% | View Analysis → |
| JRSS | JRSIS HEALTH CARE Corp | D | 90% | View Analysis → |
| HURA | TuHURA Biosciences, Inc./NV | D | 90% | View Analysis → |
| RGBPP | Regen BioPharma Inc | D | 90% | View Analysis → |
| FOXOW | FOXO TECHNOLOGIES INC. | D | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | D | 90% | View Analysis → |
| ATPC | Agape ATP Corp | D | 89% | View Analysis → |
| BOLT | Bolt Biotherapeutics, Inc. | D | 89% | View Analysis → |
| CYH | COMMUNITY HEALTH SYSTEMS INC | C | 89% | View Analysis → |
| OCEA | Ocean Biomedical, Inc. | D | 89% | View Analysis → |
| QCLS | Q/C TECHNOLOGIES, INC. | D | 88% | View Analysis → |
| PYXS | Pyxis Oncology, Inc. | D | 88% | View Analysis → |
| PHGE | BiomX Inc. | D | 88% | View Analysis → |
| OSTX | OS Therapies Inc | D | 88% | View Analysis → |
| MTNB | Matinas BioPharma Holdings, Inc. | D | 88% | View Analysis → |
| LNAI | Lunai Bioworks Inc. | D | 88% | View Analysis → |
| HCWB | HCW Biologics Inc. | D | 88% | View Analysis → |
| GOSS | Gossamer Bio, Inc. | D | 88% | View Analysis → |
| COCP | Cocrystal Pharma, Inc. | D | 88% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | D | 88% | View Analysis → |
| SIGA | SIGA TECHNOLOGIES INC | C | 88% | View Analysis → |
| DWTX | Dogwood Therapeutics, Inc. | D | 88% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | D | 88% | View Analysis → |
| KALA | KALA BIO, Inc. | D | 88% | View Analysis → |
| ENVB | Enveric Biosciences, Inc. | D | 88% | View Analysis → |
| TIL | Instil Bio, Inc. | D | 88% | View Analysis → |
| ATYR | aTYR PHARMA INC | D | 88% | View Analysis → |
| TOVX | Theriva Biologics, Inc. | D | 88% | View Analysis → |
| SSII | SS Innovations International, Inc. | C | 88% | View Analysis → |
| MBOT | Microbot Medical Inc. | C | 88% | View Analysis → |
| LUCD | Lucid Diagnostics Inc. | D | 88% | View Analysis → |
| DRIO | DarioHealth Corp. | D | 88% | View Analysis → |
| CALC | CalciMedica, Inc. | D | 88% | View Analysis → |
| AEON | AEON Biopharma, Inc. | D | 88% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | D | 88% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | D | 88% | View Analysis → |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | C | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | D | 88% | View Analysis → |
| EXOZ | EXOZYMES INC. | D | 88% | View Analysis → |
| TXMD | TherapeuticsMD, Inc. | D | 88% | View Analysis → |
| RZLT | Rezolute, Inc. | D | 88% | View Analysis → |
| BJDX | Bluejay Diagnostics, Inc. | D | 88% | View Analysis → |
| IMDX | Insight Molecular Diagnostics Inc. | D | 88% | View Analysis → |
| SRTS | Sensus Healthcare, Inc. | D | 88% | View Analysis → |
| ASRT | Assertio Holdings, Inc. | D | 88% | View Analysis → |
| AGEN | AGENUS INC | D | 88% | View Analysis → |
| CYCN | Cyclerion Therapeutics, Inc. | D | 88% | View Analysis → |
| XGN | EXAGEN INC. | D | 88% | View Analysis → |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | C | 88% | View Analysis → |
| SNGX | SOLIGENIX, INC. | D | 88% | View Analysis → |
| ATNM | Actinium Pharmaceuticals, Inc. | D | 88% | View Analysis → |
| AMLX | Amylyx Pharmaceuticals, Inc. | C | 88% | View Analysis → |
| ABSI | Absci Corp | D | 88% | View Analysis → |
| PRGO | PERRIGO Co plc | D | 88% | View Analysis → |
| MCRB | Seres Therapeutics, Inc. | D | 88% | View Analysis → |
| FTRE | Fortrea Holdings Inc. | D | 88% | View Analysis → |
| EOLS | Evolus, Inc. | C | 88% | View Analysis → |
| BDSX | BIODESIX INC | D | 88% | View Analysis → |
| BHC | Bausch Health Companies Inc. | C | 88% | View Analysis → |
| VTGN | Vistagen Therapeutics, Inc. | D | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | D | 88% | View Analysis → |
| RVRC | Revium Rx. | D | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | D | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | D | 88% | View Analysis → |
| PTIXW | Protagenic Therapeutics, Inc.new | D | 88% | View Analysis → |
| PETVW | PetVivo Holdings, Inc. | D | 88% | View Analysis → |
| OSRHW | OSR Holdings, Inc. | D | 88% | View Analysis → |
| RDGL | VIVOS INC | D | 88% | View Analysis → |
| NRXPW | NRX Pharmaceuticals, Inc. | D | 88% | View Analysis → |
| MODD | Modular Medical, Inc. | D | 88% | View Analysis → |
| IVEVF | Inventiva S.A. | C | 88% | View Analysis → |
| EUDAW | EUDA Health Holdings Ltd | D | 88% | View Analysis → |
| SLDB | Solid Biosciences Inc. | C | 87% | View Analysis → |
| RNTX | Rein Therapeutics, Inc. | D | 87% | View Analysis → |
| OMER | OMEROS CORP | D | 87% | View Analysis → |
| NKTR | NEKTAR THERAPEUTICS | D | 87% | View Analysis → |
| CLDX | Celldex Therapeutics, Inc. | D | 87% | View Analysis → |
| NUWE | Nuwellis, Inc. | D | 87% | View Analysis → |
| SCNX | Scienture Holdings, Inc. | D | 87% | View Analysis → |
| UNCY | Unicycive Therapeutics, Inc. | D | 87% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | D | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | C | 87% | View Analysis → |
| DARE | Dare Bioscience, Inc. | D | 87% | View Analysis → |
| TELA | TELA Bio, Inc. | D | 87% | View Analysis → |
| CLPT | ClearPoint Neuro, Inc. | C | 87% | View Analysis → |
| RARE | Ultragenyx Pharmaceutical Inc. | C | 87% | View Analysis → |
| CYTK | CYTOKINETICS INC | C | 87% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | D | 87% | View Analysis → |
| ISCO | International Stem Cell CORP | C | 87% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | C | 86% | View Analysis → |
| ALXO | ALX ONCOLOGY HOLDINGS INC | C | 86% | View Analysis → |
| CTXR | Citius Pharmaceuticals, Inc. | D | 86% | View Analysis → |
| FBLG | FibroBiologics, Inc. | D | 86% | View Analysis → |
| DCOY | Decoy Therapeutics Inc. | C | 86% | View Analysis → |
| RGNX | REGENXBIO Inc. | D | 86% | View Analysis → |
| KPTI | Karyopharm Therapeutics Inc. | D | 86% | View Analysis → |
| MGNX | MACROGENICS INC | C | 86% | View Analysis → |
| AQST | Aquestive Therapeutics, Inc. | C | 86% | View Analysis → |
| IBRX | ImmunityBio, Inc. | D | 86% | View Analysis → |
| ECOR | electroCore, Inc. | C | 86% | View Analysis → |
| DMAC | DiaMedica Therapeutics Inc. | D | 86% | View Analysis → |
| COGT | Cogent Biosciences, Inc. | C | 86% | View Analysis → |
| AHCO | AdaptHealth Corp. | C | 86% | View Analysis → |
| ARAY | ACCURAY INC | C | 86% | View Analysis → |
| LLY | ELI LILLY & Co | A | 86% | View Analysis → |
| DXCM | DEXCOM INC | A | 86% | View Analysis → |
| HSTC | HST Global, Inc. | D | 86% | View Analysis → |
| GRST | ETHEMA HEALTH Corp | D | 86% | View Analysis → |
| RMHI | Retrieve Medical Holdings, Inc. | D | 86% | View Analysis → |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | C | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | C | 86% | View Analysis → |
| DYNTQ | DYNATRONICS CORP | C | 86% | View Analysis → |
| VTAK | Catheter Precision, Inc. | D | 85% | View Analysis → |
| WHWK | Whitehawk Therapeutics, Inc. | D | 85% | View Analysis → |
| SYRE | Spyre Therapeutics, Inc. | D | 85% | View Analysis → |
| STRO | SUTRO BIOPHARMA, INC. | D | 85% | View Analysis → |
| SER | Serina Therapeutics, Inc. | D | 85% | View Analysis → |
| SNSE | Sensei Biotherapeutics, Inc. | C | 85% | View Analysis → |
| VOR | Vor Biopharma Inc. | D | 85% | View Analysis → |
| PGEN | PRECIGEN, INC. | D | 85% | View Analysis → |
| MTVA | MetaVia Inc. | C | 85% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | D | 85% | View Analysis → |
| TVRD | Tvardi Therapeutics, Inc. | D | 85% | View Analysis → |
| SLS | SELLAS Life Sciences Group, Inc. | C | 85% | View Analysis → |
| SPRB | SPRUCE BIOSCIENCES, INC. | D | 85% | View Analysis → |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | C | 85% | View Analysis → |
| STTK | Shattuck Labs, Inc. | C | 85% | View Analysis → |
| SKIN | Beauty Health Co | C | 85% | View Analysis → |
| XNCR | Xencor Inc | D | 85% | View Analysis → |
| AGL | agilon health, inc. | C | 85% | View Analysis → |
| VYGR | Voyager Therapeutics, Inc. | D | 85% | View Analysis → |
| PSNL | Personalis, Inc. | D | 85% | View Analysis → |
| GNLX | GENELUX Corp | D | 85% | View Analysis → |
| BBIO | BridgeBio Pharma, Inc. | C | 85% | View Analysis → |
| PTGX | Protagonist Therapeutics, Inc | C | 85% | View Analysis → |
| ZOMDF | Zomedica Corp. | D | 85% | View Analysis → |
| VYCO | VYCOR MEDICAL INC | D | 85% | View Analysis → |
| VIVS | VivoSim Labs, INC. | D | 85% | View Analysis → |
| TNONW | Tenon Medical, Inc. | D | 85% | View Analysis → |
| TLSIW | TriSalus Life Sciences, Inc. | D | 85% | View Analysis → |
| SXTPW | 60 DEGREES PHARMACEUTICALS, INC. | D | 85% | View Analysis → |
| SNNC | Sibannac, Inc. | D | 85% | View Analysis → |
| RCKTW | ROCKET PHARMACEUTICALS, INC. | D | 85% | View Analysis → |
| OWPC | One World Products, Inc. | D | 85% | View Analysis → |
| NXGLW | NEXGEL, INC. | C | 85% | View Analysis → |
| LIPO | LIPELLA PHARMACEUTICALS INC. | D | 85% | View Analysis → |
| MDNAF | Medicenna Therapeutics Corp. | C | 85% | View Analysis → |
| ENLV | Enlivex Ltd. | C | 85% | View Analysis → |
| GRDX | GridAI Technologies Corp. | C | 84% | View Analysis → |
| NNVC | NANOVIRICIDES, INC. | C | 84% | View Analysis → |
| LTRN | Lantern Pharma Inc. | C | 84% | View Analysis → |
| ALEC | Alector, Inc. | C | 84% | View Analysis → |
| ALLR | Allarity Therapeutics, Inc. | C | 84% | View Analysis → |
| MIST | Milestone Pharmaceuticals Inc. | C | 84% | View Analysis → |
| GANX | Gain Therapeutics, Inc. | C | 84% | View Analysis → |
| ELDN | Eledon Pharmaceuticals, Inc. | C | 84% | View Analysis → |
| CELC | Celcuity Inc. | C | 84% | View Analysis → |
| ADIL | ADIAL PHARMACEUTICALS, INC. | C | 84% | View Analysis → |
| NXL | Nexalin Technology, Inc. | D | 84% | View Analysis → |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | D | 84% | View Analysis → |
| GUTS | FRACTYL HEALTH, INC. | C | 84% | View Analysis → |
| INM | InMed Pharmaceuticals Inc. | C | 84% | View Analysis → |
| OCGN | Ocugen, Inc. | D | 84% | View Analysis → |
| BAX | BAXTER INTERNATIONAL INC | C | 84% | View Analysis → |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | D | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | C | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | C | 84% | View Analysis → |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | A | 84% | View Analysis → |
| ECIA | ENCISION INC | C | 84% | View Analysis → |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | C | 84% | View Analysis → |
| GTBP | GT Biopharma, Inc. | D | 83% | View Analysis → |
| LSTA | LISATA THERAPEUTICS, INC. | D | 83% | View Analysis → |
| ELUT | ELUTIA INC. | C | 83% | View Analysis → |
| CV | CapsoVision, Inc | D | 83% | View Analysis → |
| ONCY | ONCOLYTICS BIOTECH INC | D | 83% | View Analysis → |
| FHTX | Foghorn Therapeutics Inc. | C | 83% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | C | 83% | View Analysis → |
| CAPR | CAPRICOR THERAPEUTICS, INC. | C | 83% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | C | 83% | View Analysis → |
| HUMAW | Humacyte, Inc. | D | 83% | View Analysis → |
| FZMD | Fuse Medical, Inc. | C | 83% | View Analysis → |
| EVAX | Evaxion A/S | C | 83% | View Analysis → |
| NXTS | Nexentis Technologies Inc. | C | 82% | View Analysis → |
| BGLC | BioNexus Gene Lab Corp | D | 82% | View Analysis → |
| HYPD | HYPERION DEFI, INC. | D | 82% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | C | 82% | View Analysis → |
| CVKD | Cadrenal Therapeutics, Inc. | D | 82% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | C | 82% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | C | 82% | View Analysis → |
| ARTV | Artiva Biotherapeutics, Inc. | C | 82% | View Analysis → |
| ANVS | Annovis Bio, Inc. | C | 82% | View Analysis → |
| MBIO | MUSTANG BIO, INC. | C | 82% | View Analysis → |
| LGVN | Longeveron Inc. | D | 82% | View Analysis → |
| CTSO | Cytosorbents Corp | C | 82% | View Analysis → |
| CRMD | CorMedix Inc. | A | 82% | View Analysis → |
| NERV | Minerva Neurosciences, Inc. | C | 82% | View Analysis → |
| LITS | Lite Strategy, Inc. | C | 82% | View Analysis → |
| AZTR | Azitra, Inc. | C | 82% | View Analysis → |
| ALT | Altimmune, Inc. | C | 82% | View Analysis → |
| ALLO | Allogene Therapeutics, Inc. | D | 82% | View Analysis → |
| IMNN | Imunon, Inc. | D | 82% | View Analysis → |
| DCGO | DocGo Inc. | C | 82% | View Analysis → |
| BHVN | Biohaven Ltd. | C | 82% | View Analysis → |
| BMEA | Biomea Fusion, Inc. | D | 82% | View Analysis → |
| ENTX | Entera Bio Ltd. | C | 82% | View Analysis → |
| VTRS | Viatris Inc | C | 82% | View Analysis → |
| APYX | Apyx Medical Corp | C | 82% | View Analysis → |
| VNDA | Vanda Pharmaceuticals Inc. | D | 82% | View Analysis → |
| NSPR | InspireMD, Inc. | D | 82% | View Analysis → |
| QDEL | QuidelOrtho Corp | C | 82% | View Analysis → |
| IDXX | IDEXX LABORATORIES INC /DE | A+ | 82% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | C | 82% | View Analysis → |
| ALKS | Alkermes plc. | C | 82% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | A | 82% | View Analysis → |
| ADUS | Addus HomeCare Corp | A | 82% | View Analysis → |
| INDV | Indivior Pharmaceuticals, Inc. | C | 82% | View Analysis → |
| ARDX | ARDELYX, INC. | C | 82% | View Analysis → |
| UTHR | UNITED THERAPEUTICS Corp | A+ | 82% | View Analysis → |
| WVE | Wave Life Sciences Ltd. | D | 82% | View Analysis → |
| RSMDF | RESMED INC | A+ | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | D | 82% | View Analysis → |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | C | 82% | View Analysis → |
| IRD | Opus Genetics, Inc. | C | 81% | View Analysis → |
| FBRX | Forte Biosciences, Inc. | C | 81% | View Analysis → |
| ROIV | Roivant Sciences Ltd. | C | 81% | View Analysis → |
| DERM | Journey Medical Corp | C | 81% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | C | 81% | View Analysis → |
| OGEN | ORAGENICS INC | D | 81% | View Analysis → |
| CTMX | CytomX Therapeutics, Inc. | C | 81% | View Analysis → |
| ALGS | Aligos Therapeutics, Inc. | C | 81% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | A | 81% | View Analysis → |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | A | 81% | View Analysis → |
| GRI | GRI Bio, Inc. | C | 80% | View Analysis → |
| LPCN | Lipocine Inc. | C | 80% | View Analysis → |
| FEMY | FEMASYS INC | C | 80% | View Analysis → |
| CRVS | Corvus Pharmaceuticals, Inc. | C | 80% | View Analysis → |
| AYTU | AYTU BIOPHARMA, INC | C | 80% | View Analysis → |
| APRE | Aprea Therapeutics, Inc. | C | 80% | View Analysis → |
| LYEL | Lyell Immunopharma, Inc. | C | 80% | View Analysis → |
| ELMD | Electromed, Inc. | A | 80% | View Analysis → |
| ABOS | Acumen Pharmaceuticals, Inc. | C | 80% | View Analysis → |
| AVTX | Avalo Therapeutics, Inc. | D | 80% | View Analysis → |
| CATX | Perspective Therapeutics, Inc. | C | 80% | View Analysis → |
| TFX | TELEFLEX INC | C | 80% | View Analysis → |
| OMDA | Omada Health, Inc. | A | 80% | View Analysis → |
| OGN | Organon & Co. | C | 80% | View Analysis → |
| NVAX | NOVAVAX INC | C | 80% | View Analysis → |
| ELAN | Elanco Animal Health Inc | C | 80% | View Analysis → |
| BCRX | BIOCRYST PHARMACEUTICALS INC | B | 80% | View Analysis → |
| AMRX | Amneal Pharmaceuticals, Inc. | C | 80% | View Analysis → |
| OKUR | OnKure Therapeutics, Inc. | C | 80% | View Analysis → |
| DVA | DAVITA INC. | C | 80% | View Analysis → |
| ATEC | Alphatec Holdings, Inc. | C | 80% | View Analysis → |
| ADCT | ADC Therapeutics SA | C | 80% | View Analysis → |
| REGN | REGENERON PHARMACEUTICALS, INC. | A | 80% | View Analysis → |
| LUNG | Pulmonx Corp | C | 80% | View Analysis → |
| FULC | Fulcrum Therapeutics, Inc. | C | 80% | View Analysis → |
| TTRX | Turn Therapeutics Inc. | D | 80% | View Analysis → |
| IGC | IGC Pharma, Inc. | C | 80% | View Analysis → |
| MPLT | MapLight Therapeutics, Inc. | C | 80% | View Analysis → |
| FBIOP | Fortress Biotech, Inc. | C | 80% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | D | 79% | View Analysis → |
| IMUX | IMMUNIC, INC. | C | 79% | View Analysis → |
| IRIX | IRIDEX CORP | C | 79% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | C | 79% | View Analysis → |
| CLRB | Cellectar Biosciences, Inc. | C | 79% | View Analysis → |
| GNPX | Genprex, Inc. | C | 79% | View Analysis → |
| KYNB | KYNTRA BIO, INC. | C | 79% | View Analysis → |
| BOLD | Boundless Bio, Inc. | C | 79% | View Analysis → |
| BDX | BECTON DICKINSON & CO | C | 79% | View Analysis → |
| BLLN | BillionToOne, Inc. | A | 79% | View Analysis → |
| AMGN | AMGEN INC | A | 79% | View Analysis → |
| LDDD | Longduoduo Co Ltd | C | 79% | View Analysis → |
| ZBIO | Zenas BioPharma, Inc. | C | 78% | View Analysis → |
| SCYX | SCYNEXIS INC | C | 78% | View Analysis → |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | C | 78% | View Analysis → |
| FONR | FONAR CORP | B | 78% | View Analysis → |
| ACTU | ACTUATE THERAPEUTICS, INC. | C | 78% | View Analysis → |
| TRDA | Entrada Therapeutics, Inc. | C | 78% | View Analysis → |
| TECX | Tectonic Therapeutic, Inc. | C | 78% | View Analysis → |
| RNAC | Cartesian Therapeutics, Inc. | C | 78% | View Analysis → |
| HOWL | Werewolf Therapeutics, Inc. | D | 78% | View Analysis → |
| EWTX | Edgewise Therapeutics, Inc. | C | 78% | View Analysis → |
| ACRS | Aclaris Therapeutics, Inc. | C | 78% | View Analysis → |
| RNAZ | Transcode Therapeutics, Inc. | D | 78% | View Analysis → |
| TELO | Telomir Pharmaceuticals, Inc. | C | 78% | View Analysis → |
| PDSB | PDS Biotechnology Corp | D | 78% | View Analysis → |
| CNTA | Centessa Pharmaceuticals plc | C | 78% | View Analysis → |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | C | 78% | View Analysis → |
| STXS | Stereotaxis, Inc. | C | 78% | View Analysis → |
| ERAS | Erasca, Inc. | C | 78% | View Analysis → |
| EDIT | Editas Medicine, Inc. | C | 78% | View Analysis → |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | C | 78% | View Analysis → |
| CVRX | CVRx, Inc. | C | 78% | View Analysis → |
| BCAX | Bicara Therapeutics Inc. | B | 78% | View Analysis → |
| AUPH | Aurinia Pharmaceuticals Inc. | A | 78% | View Analysis → |
| ANNX | Annexon, Inc. | C | 78% | View Analysis → |
| PMVP | PMV Pharmaceuticals, Inc. | C | 78% | View Analysis → |
| CPRX | CATALYST PHARMACEUTICALS, INC. | A | 78% | View Analysis → |
| LONA | LeonaBio, Inc. | C | 78% | View Analysis → |
| ZTS | Zoetis Inc. | A | 78% | View Analysis → |
| SMMT | Summit Therapeutics Inc. | C | 78% | View Analysis → |
| QNRX | Quoin Pharmaceuticals, Ltd. | D | 78% | View Analysis → |
| GILD | GILEAD SCIENCES, INC. | A | 78% | View Analysis → |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | C | 78% | View Analysis → |
| USPH | U S PHYSICAL THERAPY INC /NV | C | 78% | View Analysis → |
| ABBV | AbbVie Inc. | C | 78% | View Analysis → |
| URGN | UroGen Pharma Ltd. | C | 78% | View Analysis → |
| TKNO | Alpha Teknova, Inc. | C | 78% | View Analysis → |
| SGHT | Sight Sciences, Inc. | C | 78% | View Analysis → |
| LFCR | LIFECORE BIOMEDICAL, INC. DE | C | 78% | View Analysis → |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C | 78% | View Analysis → |
| GERN | GERON CORP | C | 78% | View Analysis → |
| BRNS | Barinthus Biotherapeutics plc. | C | 78% | View Analysis → |
| AMPH | Amphastar Pharmaceuticals, Inc. | C | 78% | View Analysis → |
| VCYT | VERACYTE, INC. | A | 78% | View Analysis → |
| STIM | Neuronetics, Inc. | C | 78% | View Analysis → |
| SGRY | Surgery Partners, Inc. | C | 78% | View Analysis → |
| SDGR | Schrodinger, Inc. | C | 78% | View Analysis → |
| PNTG | Pennant Group, Inc. | C | 78% | View Analysis → |
| MYGN | MYRIAD GENETICS INC | C | 78% | View Analysis → |
| MD | Pediatrix Medical Group, Inc. | C | 78% | View Analysis → |
| PEN | Penumbra Inc | A | 78% | View Analysis → |
| IRMD | IRADIMED CORP | A | 78% | View Analysis → |
| SEM | SELECT MEDICAL HOLDINGS CORP | C | 78% | View Analysis → |
| PCRX | Pacira BioSciences, Inc. | C | 78% | View Analysis → |
| MRK | Merck & Co., Inc. | B | 78% | View Analysis → |
| EBS | Emergent BioSolutions Inc. | C | 78% | View Analysis → |
| CERS | CERUS CORP | C | 78% | View Analysis → |
| MDXG | MIMEDX GROUP, INC. | C | 78% | View Analysis → |
| IONS | IONIS PHARMACEUTICALS INC | C | 78% | View Analysis → |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C | 78% | View Analysis → |
| TERN | Terns Pharmaceuticals, Inc. | C | 78% | View Analysis → |
| SBFMW | Sunshine Biopharma Inc. | C | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | D | 78% | View Analysis → |
| PTPI | Petros Pharmaceuticals, Inc. | D | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | C | 78% | View Analysis → |
| PLYX | Polaryx Therapeutics, Inc. | C | 78% | View Analysis → |
| OABIW | OmniAb, Inc. | C | 78% | View Analysis → |
| NEOG | NEOGEN CORP | C | 78% | View Analysis → |
| NAMSW | NewAmsterdam Pharma Co N.V. | C | 78% | View Analysis → |
| KPHMW | KIORA PHARMACEUTICALS INC | C | 78% | View Analysis → |
| GIPL | Global Innovative Platforms Inc. | C | 78% | View Analysis → |
| IXHL | Incannex Healthcare Inc. | C | 77% | View Analysis → |
| CABA | Cabaletta Bio, Inc. | C | 77% | View Analysis → |
| ACOG | Alpha Cognition Inc. | C | 77% | View Analysis → |
| EDSA | Edesa Biotech, Inc. | C | 77% | View Analysis → |
| CCCC | C4 Therapeutics, Inc. | C | 77% | View Analysis → |
| ARVN | ARVINAS, INC. | C | 77% | View Analysis → |
| SYK | STRYKER CORP | A | 77% | View Analysis → |
| LNSR | LENSAR, Inc. | C | 77% | View Analysis → |
| RMTI | ROCKWELL MEDICAL, INC. | C | 77% | View Analysis → |
| CRNX | Crinetics Pharmaceuticals, Inc. | C | 77% | View Analysis → |
| CNTX | Context Therapeutics Inc. | C | 77% | View Analysis → |
| LMAT | LEMAITRE VASCULAR INC | A | 77% | View Analysis → |
| INSP | Inspire Medical Systems, Inc. | A | 77% | View Analysis → |
| CYRX | Cryoport, Inc. | C | 77% | View Analysis → |
| BSX | BOSTON SCIENTIFIC CORP | A | 77% | View Analysis → |
| UNH | UNITEDHEALTH GROUP INC | B | 77% | View Analysis → |
| NEUP | Neuphoria Therapeutics Inc. | C | 76% | View Analysis → |
| NKTX | Nkarta, Inc. | C | 76% | View Analysis → |
| CMPS | COMPASS Pathways plc | C | 76% | View Analysis → |
| AARD | Aardvark Therapeutics, Inc. | C | 76% | View Analysis → |
| COYA | Coya Therapeutics, Inc. | C | 76% | View Analysis → |
| CGON | CG Oncology, Inc. | C | 76% | View Analysis → |
| ATOS | ATOSSA THERAPEUTICS, INC. | C | 76% | View Analysis → |
| ACET | Adicet Bio, Inc. | C | 76% | View Analysis → |
| HROW | HARROW, INC. | C | 76% | View Analysis → |
| AVBP | ArriVent BioPharma, Inc. | C | 76% | View Analysis → |
| KURA | Kura Oncology, Inc. | C | 76% | View Analysis → |
| TNDM | TANDEM DIABETES CARE INC | C | 76% | View Analysis → |
| ARCT | Arcturus Therapeutics Holdings Inc. | C | 76% | View Analysis → |
| OSUR | ORASURE TECHNOLOGIES INC | C | 76% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | C | 76% | View Analysis → |
| AORT | ARTIVION, INC. | C | 76% | View Analysis → |
| MIRM | Mirum Pharmaceuticals, Inc. | B | 76% | View Analysis → |
| IRON | Disc Medicine, Inc. | C | 76% | View Analysis → |
| ADMA | ADMA BIOLOGICS, INC. | A | 76% | View Analysis → |
| ACAD | ACADIA PHARMACEUTICALS INC | C | 76% | View Analysis → |
| HRMY | Harmony Biosciences Holdings, Inc. | A | 76% | View Analysis → |
| MASI | MASIMO CORP | A | 76% | View Analysis → |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | C | 76% | View Analysis → |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | 76% | View Analysis → |
| AXSM | Axsome Therapeutics, Inc. | C | 76% | View Analysis → |
| MRNA | Moderna, Inc. | C | 76% | View Analysis → |
| LH | LABCORP HOLDINGS INC. | A | 76% | View Analysis → |
| KIDS | ORTHOPEDIATRICS CORP | C | 76% | View Analysis → |
| ITGR | Integer Holdings Corp | C | 76% | View Analysis → |
| ANIK | Anika Therapeutics, Inc. | C | 76% | View Analysis → |
| CDNA | CareDx, Inc. | C | 76% | View Analysis → |
| HCA | HCA Healthcare, Inc. | A | 76% | View Analysis → |
| ELV | Elevance Health, Inc. | B | 76% | View Analysis → |
| PULM | Pulmatrix, Inc. | D | 75% | View Analysis → |
| HIND | Vyome Holdings, Inc | C | 75% | View Analysis → |
| VYNE | VYNE Therapeutics Inc. | C | 75% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | C | 75% | View Analysis → |
| JANX | Janux Therapeutics, Inc. | C | 75% | View Analysis → |
| ZNTL | Zentalis Pharmaceuticals, Inc. | C | 75% | View Analysis → |
| XBIT | XBiotech Inc. | D | 75% | View Analysis → |
| VERU | VERU INC. | C | 75% | View Analysis → |
| ANRO | Alto Neuroscience, Inc. | C | 75% | View Analysis → |
| CADL | Candel Therapeutics, Inc. | C | 75% | View Analysis → |
| ANTX | AN2 Therapeutics, Inc. | C | 75% | View Analysis → |
| ENTA | ENANTA PHARMACEUTICALS INC | C | 75% | View Analysis → |
| PMN | ProMIS Neurosciences Inc. | C | 75% | View Analysis → |
| NRXS | Neuraxis, INC | C | 75% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | C | 75% | View Analysis → |
| UTMD | UTAH MEDICAL PRODUCTS INC | B | 75% | View Analysis → |
| PRLD | Prelude Therapeutics Inc | D | 75% | View Analysis → |
| ZLAB | Zai Lab Ltd | C | 75% | View Analysis → |
| PRVA | Privia Health Group, Inc. | C | 75% | View Analysis → |
| PGNY | Progyny, Inc. | B | 75% | View Analysis → |
| PDEX | PRO DEX INC | A | 75% | View Analysis → |
| PBYI | PUMA BIOTECHNOLOGY, INC. | C | 75% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | C | 75% | View Analysis → |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | A | 75% | View Analysis → |
| INNV | InnovAge Holding Corp. | C | 75% | View Analysis → |
| TECH | BIO-TECHNE Corp | B | 75% | View Analysis → |
| PRAX | Praxis Precision Medicines, Inc. | C | 75% | View Analysis → |
| SRPT | Sarepta Therapeutics, Inc. | C | 75% | View Analysis → |
| SOLV | Solventum Corp | C | 75% | View Analysis → |
| EXEL | EXELIXIS, INC. | A | 75% | View Analysis → |
| EMBC | Embecta Corp. | B | 75% | View Analysis → |
| MMSI | MERIT MEDICAL SYSTEMS INC | A | 75% | View Analysis → |
| IRTC | iRhythm Holdings, Inc. | C | 75% | View Analysis → |
| EHC | Encompass Health Corp | A | 75% | View Analysis → |
| CORT | CORCEPT THERAPEUTICS INC | C | 75% | View Analysis → |
| ALHC | Alignment Healthcare, Inc. | A | 75% | View Analysis → |
| AMRN | AMARIN CORP PLCUK | C | 75% | View Analysis → |
| AXGN | Axogen, Inc. | C | 75% | View Analysis → |
| MMM | 3M CO | B | 75% | View Analysis → |
| PMDI | PSYCHEMEDICS CORP | C | 75% | View Analysis → |
| PCYN | PROCYON CORP | C | 75% | View Analysis → |
| AURA | Aura Biosciences, Inc. | C | 74% | View Analysis → |
| AUTL | Autolus Therapeutics plc | C | 74% | View Analysis → |
| AMS | AMERICAN SHARED HOSPITAL SERVICES | C | 74% | View Analysis → |
| KOD | Kodiak Sciences Inc. | C | 74% | View Analysis → |
| KAPA | Kairos Pharma, LTD. | C | 74% | View Analysis → |
| ELVN | Enliven Therapeutics, Inc. | C | 74% | View Analysis → |
| ABUS | Arbutus Biopharma Corp | C | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | C | 74% | View Analysis → |
| CNTN | Canton Strategic Holdings, Inc. | C | 74% | View Analysis → |
| RDNT | RadNet, Inc. | C | 74% | View Analysis → |
| OBIO | Orchestra BioMed Holdings, Inc. | C | 74% | View Analysis → |
| BDTX | Black Diamond Therapeutics, Inc. | C | 74% | View Analysis → |
| NGNE | Neurogene Inc. | C | 74% | View Analysis → |
| ANIP | ANI PHARMACEUTICALS INC | A | 74% | View Analysis → |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C | 74% | View Analysis → |
| INMB | Inmune Bio, Inc. | C | 74% | View Analysis → |
| GMED | GLOBUS MEDICAL INC | A | 74% | View Analysis → |
| BIOA | BioAge Labs, Inc. | B | 74% | View Analysis → |
| MNKD | MANNKIND CORP | C | 74% | View Analysis → |
| INVA | Innoviva, Inc. | A | 74% | View Analysis → |
| ARQT | Arcutis Biotherapeutics, Inc. | C | 74% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | C | 74% | View Analysis → |
| UHS | UNIVERSAL HEALTH SERVICES INC | A | 74% | View Analysis → |
| ARDT | Ardent Health, Inc. | C | 74% | View Analysis → |
| ADPT | Adaptive Biotechnologies Corp | B | 74% | View Analysis → |
| FLGT | Fulgent Genetics, Inc. | C | 74% | View Analysis → |
| OPCH | Option Care Health, Inc. | B | 74% | View Analysis → |
| OPK | OPKO HEALTH, INC. | C | 74% | View Analysis → |
| PFG | PRINCIPAL FINANCIAL GROUP INC | C | 74% | View Analysis → |
| ABT | ABBOTT LABORATORIES | B | 74% | View Analysis → |
| WST | WEST PHARMACEUTICAL SERVICES INC | A | 74% | View Analysis → |
| LGNZZ | LIGAND PHARMACEUTICALS INC | A | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | D | 74% | View Analysis → |
| NUVL | Nuvalent, Inc. | C | 73% | View Analysis → |
| ICCC | IMMUCELL CORP /DE/ | A | 73% | View Analysis → |
| BEAM | Beam Therapeutics Inc. | B | 73% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | C | 73% | View Analysis → |
| CHE | CHEMED CORP | A | 73% | View Analysis → |
| MRKR | Marker Therapeutics, Inc. | C | 72% | View Analysis → |
| TBPH | Theravance Biopharma, Inc. | A | 72% | View Analysis → |
| SGMT | Sagimet Biosciences Inc. | C | 72% | View Analysis → |
| RAPP | Rapport Therapeutics, Inc. | C | 72% | View Analysis → |
| PRME | Prime Medicine, Inc. | C | 72% | View Analysis → |
| PLSE | PULSE BIOSCIENCES, INC. | C | 72% | View Analysis → |
| IMA | ImageneBio, Inc. | C | 72% | View Analysis → |
| DYN | Dyne Therapeutics, Inc. | C | 72% | View Analysis → |
| AVAH | Aveanna Healthcare Holdings, Inc. | C | 72% | View Analysis → |
| RANI | Rani Therapeutics Holdings, Inc. | C | 72% | View Analysis → |
| PROK | PROKIDNEY CORP. | C | 72% | View Analysis → |
| TLPH | TALPHERA, INC. | C | 72% | View Analysis → |
| ORKA | Oruka Therapeutics, Inc. | C | 72% | View Analysis → |
| BNTC | Benitec Biopharma Inc. | C | 72% | View Analysis → |
| ABEO | ABEONA THERAPEUTICS INC. | C | 72% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | C | 72% | View Analysis → |
| XBIO | Xenetic Biosciences, Inc. | C | 72% | View Analysis → |
| SPRO | Spero Therapeutics, Inc. | C | 72% | View Analysis → |
| QNCX | Quince Therapeutics, Inc. | C | 72% | View Analysis → |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | C | 72% | View Analysis → |
| MXCT | MAXCYTE, INC. | C | 72% | View Analysis → |
| TNXP | Tonix Pharmaceuticals Holding Corp. | C | 72% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | C | 72% | View Analysis → |
| AVIR | Atea Pharmaceuticals, Inc. | C | 72% | View Analysis → |
| ABCL | AbCellera Biologics Inc. | C | 72% | View Analysis → |
| SNWV | SANUWAVE Health, Inc. | C | 72% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | C | 72% | View Analysis → |
| NXTC | NextCure, Inc. | C | 72% | View Analysis → |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | C | 72% | View Analysis → |
| LFST | LifeStance Health Group, Inc. | C | 72% | View Analysis → |
| INFU | InfuSystem Holdings, Inc | A | 72% | View Analysis → |
| DCTH | DELCATH SYSTEMS, INC. | A | 72% | View Analysis → |
| CAI | Caris Life Sciences, Inc. | A | 72% | View Analysis → |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | C | 72% | View Analysis → |
| ESPR | Esperion Therapeutics, Inc. | C | 72% | View Analysis → |
| TNYA | Tenaya Therapeutics, Inc. | C | 72% | View Analysis → |
| RPRX | Royalty Pharma plc | B | 72% | View Analysis → |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C | 72% | View Analysis → |
| LNTH | Lantheus Holdings, Inc. | A | 72% | View Analysis → |
| DSGN | Design Therapeutics, Inc. | C | 72% | View Analysis → |
| CSTL | CASTLE BIOSCIENCES INC | C | 72% | View Analysis → |
| NATR | NATURES SUNSHINE PRODUCTS INC | B | 72% | View Analysis → |
| JBIO | Jade Biosciences, Inc. | C | 72% | View Analysis → |
| VRDN | Viridian Therapeutics, Inc.\DE | D | 72% | View Analysis → |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C | 72% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | C | 72% | View Analysis → |
| NVNO | enVVeno Medical Corp | C | 72% | View Analysis → |
| AFL | AFLAC INC | C | 72% | View Analysis → |
| NRC | NATIONAL RESEARCH CORP | C | 72% | View Analysis → |
| TWST | Twist Bioscience Corp | B | 72% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | C | 72% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | C | 72% | View Analysis → |
| HUM | HUMANA INC | B | 72% | View Analysis → |
| BIIB | BIOGEN INC. | B | 72% | View Analysis → |
| INCY | INCYTE CORP | A | 72% | View Analysis → |
| MEDP | Medpace Holdings, Inc. | A | 72% | View Analysis → |
| BBNX | Beta Bionics, Inc. | C | 72% | View Analysis → |
| VREOF | Vireo Growth Inc. | C | 72% | View Analysis → |
| VASO | VASO Corp | B | 72% | View Analysis → |
| USAQ | QHSLab, Inc. | C | 72% | View Analysis → |
| UNMA | Unum Group | C | 72% | View Analysis → |
| LIFD | LFTD PARTNERS INC. | C | 72% | View Analysis → |
| LIANY | LianBio | C | 72% | View Analysis → |
| GRTX | Galera Therapeutics, Inc. | C | 72% | View Analysis → |
| REVBW | REVELATION BIOSCIENCES, INC. | C | 72% | View Analysis → |
| NRIX | Nurix Therapeutics, Inc. | C | 72% | View Analysis → |
| MDNC | Medinotec Inc. | A | 72% | View Analysis → |
| HAE | HAEMONETICS CORP | B | 71% | View Analysis → |
| NTLA | Intellia Therapeutics, Inc. | C | 71% | View Analysis → |
| IVVD | Invivyd, Inc. | C | 71% | View Analysis → |
| ALDX | Aldeyra Therapeutics, Inc. | C | 71% | View Analysis → |
| HYPR | Hyperfine, Inc. | C | 71% | View Analysis → |
| IMNM | Immunome Inc. | C | 71% | View Analysis → |
| CBLL | Ceribell, Inc. | B | 71% | View Analysis → |
| APGE | Apogee Therapeutics, Inc. | C | 71% | View Analysis → |
| IBIO | iBio, Inc. | C | 71% | View Analysis → |
| GRAL | GRAIL, Inc. | C | 71% | View Analysis → |
| OFIX | Orthofix Medical Inc. | C | 71% | View Analysis → |
| ATRC | AtriCure, Inc. | B | 71% | View Analysis → |
| OCUL | OCULAR THERAPEUTIX, INC | C | 71% | View Analysis → |
| IMVT | Immunovant, Inc. | C | 70% | View Analysis → |
| RNXT | RenovoRx, Inc. | C | 70% | View Analysis → |
| RLYB | Rallybio Corp | C | 70% | View Analysis → |
| PLRX | PLIANT THERAPEUTICS, INC. | B | 70% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | C | 70% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | B | 70% | View Analysis → |
| CTNM | Contineum Therapeutics, Inc. | C | 70% | View Analysis → |
| CLYM | Climb Bio, Inc. | C | 70% | View Analysis → |
| CBIO | CRESCENT BIOPHARMA, INC. | C | 70% | View Analysis → |
| ACRV | Acrivon Therapeutics, Inc. | C | 70% | View Analysis → |
| MNOV | MEDICINOVA INC | C | 70% | View Analysis → |
| ETON | Eton Pharmaceuticals, Inc. | A | 70% | View Analysis → |
| PASG | Passage BIO, Inc. | C | 70% | View Analysis → |
| RLMD | RELMADA THERAPEUTICS, INC. | C | 70% | View Analysis → |
| MBX | MBX Biosciences, Inc. | B | 70% | View Analysis → |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C | 70% | View Analysis → |
| VCEL | Vericel Corp | B | 70% | View Analysis → |
| STOK | Stoke Therapeutics, Inc. | C | 70% | View Analysis → |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | A | 70% | View Analysis → |
| TARS | Tarsus Pharmaceuticals, Inc. | A | 70% | View Analysis → |
| PODD | INSULET CORP | B | 70% | View Analysis → |
| MLYS | Mineralys Therapeutics, Inc. | C | 70% | View Analysis → |
| RGEN | REPLIGEN CORP | A | 70% | View Analysis → |
| CARL | CARLSMED, INC. | B | 70% | View Analysis → |
| BVS | Bioventus Inc. | C | 70% | View Analysis → |
| TGTX | TG THERAPEUTICS, INC. | C | 70% | View Analysis → |
| HSIC | HENRY SCHEIN INC | A | 70% | View Analysis → |
| GKOS | GLAUKOS Corp | B | 70% | View Analysis → |
| TALKW | Talkspace, Inc. | A | 70% | View Analysis → |
| LEXX | Lexaria Bioscience Corp. | C | 70% | View Analysis → |
| LBRX | LB PHARMACEUTICALS INC | C | 70% | View Analysis → |
| RFL | Rafael Holdings, Inc. | C | 70% | View Analysis → |
| EXAS | EXACT SCIENCES CORP | B | 70% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | C | 69% | View Analysis → |
| CAMP | Camp4 Therapeutics Corp | C | 69% | View Analysis → |
| LIVN | LivaNova PLC | B | 69% | View Analysis → |
| GRCE | Grace Therapeutics, Inc. | B | 69% | View Analysis → |
| XLO | Xilio Therapeutics, Inc. | B | 68% | View Analysis → |
| PEPG | PepGen Inc. | C | 68% | View Analysis → |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | C | 68% | View Analysis → |
| PBH | Prestige Consumer Healthcare Inc. | B | 68% | View Analysis → |
| ATAI | Atai Beckley N.V. | C | 68% | View Analysis → |
| LRMR | Larimar Therapeutics, Inc. | C | 68% | View Analysis → |
| OVID | Ovid Therapeutics Inc. | C | 68% | View Analysis → |
| MREO | Mereo BioPharma Group plc | C | 68% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | C | 68% | View Analysis → |
| XTNT | Xtant Medical Holdings, Inc. | C | 68% | View Analysis → |
| TNGX | Tango Therapeutics, Inc. | B | 68% | View Analysis → |
| SION | Sionna Therapeutics, Inc. | B | 68% | View Analysis → |
| MLTX | MoonLake Immunotherapeutics | C | 68% | View Analysis → |
| LQDA | Liquidia Corp | A | 68% | View Analysis → |
| ANAB | ANAPTYSBIO, INC | B | 68% | View Analysis → |
| ZYME | Zymeworks Inc. | C | 68% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | C | 68% | View Analysis → |
| PRTA | PROTHENA CORP PUBLIC LTD CO | C | 68% | View Analysis → |
| BLFS | BIOLIFE SOLUTIONS INC | B | 68% | View Analysis → |
| PAHC | PHIBRO ANIMAL HEALTH CORP | B | 68% | View Analysis → |
| EHAB | Enhabit, Inc. | C | 68% | View Analysis → |
| TMDX | TransMedics Group, Inc. | B | 68% | View Analysis → |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | 68% | View Analysis → |
| JAZZ | Jazz Pharmaceuticals plc | C | 68% | View Analysis → |
| TVTX | Travere Therapeutics, Inc. | B | 68% | View Analysis → |
| NUVB | Nuvation Bio Inc. | B | 68% | View Analysis → |
| TRUP | TRUPANION, INC. | A | 68% | View Analysis → |
| THC | TENET HEALTHCARE CORP | B | 68% | View Analysis → |
| CI | Cigna Group | B | 68% | View Analysis → |
| CNC | CENTENE CORP | C | 68% | View Analysis → |
| XOMAP | XOMA Royalty Corp | B | 68% | View Analysis → |
| WGSWW | GeneDx Holdings Corp. | A | 68% | View Analysis → |
| PFHO | PACIFIC HEALTH CARE ORGANIZATION INC | B | 68% | View Analysis → |
| INBP | INTEGRATED BIOPHARMA INC | C | 68% | View Analysis → |
| FOLD | AMICUS THERAPEUTICS, INC. | A | 68% | View Analysis → |
| ADVB | Advanced Biomed Inc. | C | 67% | View Analysis → |
| IMMX | Immix Biopharma, Inc. | C | 67% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | C | 67% | View Analysis → |
| CUE | Cue Biopharma, Inc. | C | 67% | View Analysis → |
| BCYC | BICYCLE THERAPEUTICS PLC | B | 67% | View Analysis → |
| APLS | Apellis Pharmaceuticals, Inc. | A | 67% | View Analysis → |
| NVCT | Nuvectis Pharma, Inc. | C | 67% | View Analysis → |
| KTTAW | Pasithea Therapeutics Corp. | C | 67% | View Analysis → |
| HTFL | Heartflow, Inc. | B | 66% | View Analysis → |
| AKBA | Akebia Therapeutics, Inc. | C | 66% | View Analysis → |
| MIRA | MIRA PHARMACEUTICALS, INC. | C | 66% | View Analysis → |
| ALMS | ALUMIS INC. | C | 66% | View Analysis → |
| MNPR | Monopar Therapeutics | C | 66% | View Analysis → |
| OLMA | Olema Pharmaceuticals, Inc. | C | 66% | View Analysis → |
| NPCE | NeuroPace Inc | C | 66% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | C | 66% | View Analysis → |
| NEPH | NEPHROS INC | A | 66% | View Analysis → |
| ICUI | ICU MEDICAL INC/DE | B | 66% | View Analysis → |
| KRMD | KORU Medical Systems, Inc. | A | 66% | View Analysis → |
| INAB | IN8BIO, INC. | C | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | A | 66% | View Analysis → |
| RIGL | RIGEL PHARMACEUTICALS INC | B | 66% | View Analysis → |
| ORIC | Oric Pharmaceuticals, Inc. | C | 66% | View Analysis → |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | 66% | View Analysis → |
| SEPN | Septerna, Inc. | C | 65% | View Analysis → |
| PHIO | Phio Pharmaceuticals Corp. | B | 65% | View Analysis → |
| ZURA | Zura Bio Ltd | B | 65% | View Analysis → |
| IMRX | Immuneering Corp | C | 65% | View Analysis → |
| SI | SHOULDER INNOVATIONS, INC. | B | 65% | View Analysis → |
| UPB | Upstream Bio, Inc. | B | 65% | View Analysis → |
| XERS | Xeris Biopharma Holdings, Inc. | B | 65% | View Analysis → |
| PROF | Profound Medical Corp. | B | 65% | View Analysis → |
| VIR | Vir Biotechnology, Inc. | C | 65% | View Analysis → |
| TSHA | Taysha Gene Therapies, Inc. | B | 65% | View Analysis → |
| PTCT | PTC THERAPEUTICS, INC. | B | 65% | View Analysis → |
| RCUS | Arcus Biosciences, Inc. | C | 65% | View Analysis → |
| PHAT | Phathom Pharmaceuticals, Inc. | C | 65% | View Analysis → |
| IDXG | INTERPACE BIOSCIENCES, INC. | B | 65% | View Analysis → |
| ICUCW | SeaStar Medical Holding Corp | C | 65% | View Analysis → |
| EQ | Equillium, Inc. | C | 64% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | B | 64% | View Analysis → |
| GYRE | GYRE THERAPEUTICS, INC. | B | 64% | View Analysis → |
| NTRA | Natera, Inc. | A | 64% | View Analysis → |
| INSM | INSMED Inc | C | 64% | View Analysis → |
| LFVN | Lifevantage Corp | B | 64% | View Analysis → |
| MOH | MOLINA HEALTHCARE, INC. | C | 64% | View Analysis → |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | B | 64% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | C | 64% | View Analysis → |
| ACXP | Acurx Pharmaceuticals, Inc. | C | 63% | View Analysis → |
| IQV | IQVIA HOLDINGS INC. | A | 63% | View Analysis → |
| PRCT | PROCEPT BioRobotics Corp | B | 63% | View Analysis → |
| VTVT | vTv Therapeutics Inc. | B | 62% | View Analysis → |
| TYRA | Tyra Biosciences, Inc. | B | 62% | View Analysis → |
| GPCR | Structure Therapeutics Inc. | B | 62% | View Analysis → |
| HOTH | Hoth Therapeutics, Inc. | C | 62% | View Analysis → |
| ORGO | Organogenesis Holdings Inc. | C | 62% | View Analysis → |
| UFPT | UFP TECHNOLOGIES INC | B | 62% | View Analysis → |
| ZVRA | ZEVRA THERAPEUTICS, INC. | B | 62% | View Analysis → |
| SLNO | SOLENO THERAPEUTICS INC | A | 62% | View Analysis → |
| SHC | Sotera Health Co | C | 62% | View Analysis → |
| OSCR | Oscar Health, Inc. | B | 61% | View Analysis → |
| NVCR | NovoCure Ltd | B | 61% | View Analysis → |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | C | 60% | View Analysis → |
| PFE | PFIZER INC | B | 60% | View Analysis → |
| NNNN | Anbio Biotechnology | C | 60% | View Analysis → |
| KRRO | Korro Bio, Inc. | C | 59% | View Analysis → |
| DGX | QUEST DIAGNOSTICS INC | C | 59% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | C | 58% | View Analysis → |
| VRCA | Verrica Pharmaceuticals Inc. | B | 58% | View Analysis → |
| OM | Outset Medical, Inc. | C | 58% | View Analysis → |
| VMD | VIEMED HEALTHCARE, INC. | B | 58% | View Analysis → |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | B | 58% | View Analysis → |
| MSLE | Satellos Bioscience Inc. | C | 58% | View Analysis → |
| GLSI | Greenwich LifeSciences, Inc. | C | 57% | View Analysis → |
| KROS | Keros Therapeutics, Inc. | A | 57% | View Analysis → |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 56% | View Analysis → |
| HOOK | HOOKIPA Pharma Inc. | C | 56% | View Analysis → |
| KZR | Kezar Life Sciences, Inc. | C | 55% | View Analysis → |
| PALI | PALISADE BIO, INC. | B | 55% | View Analysis → |
| SIBN | SI-BONE, Inc. | B | 55% | View Analysis → |
| PVLA | PALVELLA THERAPEUTICS, INC. | B | 55% | View Analysis → |
| MDLN | Medline Inc. | C | 55% | View Analysis → |
| SRTAW | Strata Critical Medical, Inc. | B | 55% | View Analysis → |
| IDYA | IDEAYA Biosciences, Inc. | B | 54% | View Analysis → |
| KALV | KalVista Pharmaceuticals, Inc. | B | 54% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | B | 52% | View Analysis → |
| ETST | Earth Science Tech, Inc. | B | 52% | View Analysis → |
| TRVI | Trevi Therapeutics, Inc. | C | 50% | View Analysis → |
| TCRX | TScan Therapeutics, Inc. | C | 50% | View Analysis → |
| SNDX | Syndax Pharmaceuticals Inc | B | 48% | View Analysis → |
| VXRT | Vaxart, Inc. | B | 48% | View Analysis → |
| GENB | Generate Biomedicines, Inc. | C | 46% | View Analysis → |
| VKTX | Viking Therapeutics, Inc. | C | 45% | View Analysis → |
| TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | B | 45% | View Analysis → |
| GDTC | CytoMed Therapeutics Ltd | C | 44% | View Analysis → |
| EVOTF | Evotec SE | C | 44% | View Analysis → |
| XENE | Xenon Pharmaceuticals Inc. | B | 42% | View Analysis → |
| VSTM | Verastem, Inc. | B | 42% | View Analysis → |
| INMD | InMode Ltd. | B | 42% | View Analysis → |
| FMCQF | Fresenius Medical Care AG | B | 41% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | B | 41% | View Analysis → |
| GHRS | GH Research PLC | B | 40% | View Analysis → |
| EDAP | EDAP TMS SA | B | 39% | View Analysis → |
| QTTB | Q32 Bio Inc. | C | 35% | View Analysis → |
| TENX | TENAX THERAPEUTICS, INC. | B | 35% | View Analysis → |
| VERA | Vera Therapeutics, Inc. | D | 35% | View Analysis → |
| SYBX | SYNLOGIC, INC. | D | 35% | View Analysis → |
| RLFTF | Relief Therapeutics Holding SA | C | 32% | View Analysis → |
| RNA | Atrium Therapeutics, Inc. | C | 21% | View Analysis → |
| NRSNW | NeuroSense Therapeutics Ltd. | B | 20% | View Analysis → |
| LMRI | Lumexa Imaging Holdings, Inc. | B | 18% | View Analysis → |
| NSRX | Nasus Pharma Ltd | B | 18% | View Analysis → |
| NONOF | NOVO NORDISK A S | B | 18% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | B | 18% | View Analysis → |
| MMED | MiniMed Group, Inc. | C | 18% | View Analysis → |
| RDHL | RedHill Biopharma Ltd. | B | 16% | View Analysis → |
| RDY | DR REDDYS LABORATORIES LTD | B | 15% | View Analysis → |
| RDPTF | Radiopharm Theranostics Ltd | B | 14% | View Analysis → |
| PARK | Park Dental Partners, Inc. | B | 5% | View Analysis → |
| MEOBF | MESOBLAST LTD | B | 5% | View Analysis → |
| MDXH | MDxHealth SA | B | 5% | View Analysis → |
Frequently Asked Questions: Healthcare Stocks
What are the best healthcare stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 74 healthcare stocks have A+ or A grades in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which healthcare stocks have A+ grades?
Currently, 3 healthcare stocks have an A+ grade from our AI analysis. A+ indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze healthcare stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Healthcare stocks with 80%+ confidence have the most reliable ratings.
Should I invest in healthcare stocks in 2026?
Our AI analysis shows 74 Buy ratings vs 713 Sell ratings in the healthcare sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are healthcare stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most healthcare stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for healthcare stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.